Luke Walker

Business address
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA, 98121
Top holdings (ownership)
ZNTL
Get insider transactions for this reporting owner
Luke Walker has filed 19 SEC EDGAR filings since 20 Mar 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 18 Jun 2025 17 Jun 2025 001-39263
4 Open Document Open Filing FORM 4 12 Jun 2025 12 Jun 2025 001-40654
4 Open Document Open Filing FORM 4 04 Feb 2025 31 Jan 2025 001-39263
4 Open Document Open Filing FORM 4 05 Sep 2024 04 Sep 2024 001-40654
3 Open Document Open Filing FORM 3 05 Sep 2024 04 Sep 2024 001-40654
4 Open Document Open Filing FORM 4 29 May 2024 24 May 2024 001-39263
3 Open Document Open Filing FORM 3 29 May 2024 24 May 2024 001-39263
4 Open Document Open Filing 4 11 Mar 2024 11 Mar 2024 001-38800
4 Open Document Open Filing 4 09 Jan 2024 07 Jan 2024 001-38800
4 Open Document Open Filing FORM 4 SUBMISSION 28 Nov 2023 26 Nov 2023 001-38800
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jan 2023 24 Jan 2023 001-38800
4 Open Document Open Filing FORM 4 SUBMISSION 04 Oct 2022 03 Oct 2022 001-38800
3 Open Document Open Filing FORM 3 SUBMISSION 04 Oct 2022 03 Oct 2022 001-38800
4 Open Document Open Filing FORM 4 SUBMISSION 13 Mar 2018 09 Mar 2018 001-33882
5 Open Document Open Filing FORM 5 SUBMISSION 14 Feb 2018 31 Dec 2017 001-33882
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2018 01 Feb 2018 001-33882
4 Open Document Open Filing FORM 4 SUBMISSION 16 Jan 2018 11 Jan 2018 001-33882
4 Open Document Open Filing FORM 4 SUBMISSION 20 Sep 2017 18 Sep 2017 001-33882
3 Open Document Open Filing FORM 3 SUBMISSION 20 Mar 2017 09 Mar 2017 001-33882